DPP7: A Protein with Potential as A Drug Target Or Biomarker (G29952)

Target Name: DPP7

NCBI ID: G29952

DPP7

DPP7: A Protein with Potential as A Drug Target Or Biomarker

DPP7 (doublecortin) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the superfamily of calbindin-related proteins, which are involved in a variety of cellular processes, including stress responses, cell signaling, and tissue regeneration.

DPP7 has been identified as a potential drug target or biomarker for a variety of diseases, including neurodegenerative disorders, chronic pain, and inflammatory diseases. Its unique structure and function have made it an attractive target for researchers to study, and its potential as a drug or biomarker has led to a significant amount of research in the field.

One of the key reasons for the interest in DPP7 is its ability to interact with a variety of molecules, including neurotransmitters, cytokines, and signaling proteins. Itscalbindin-like domains, which are found in various proteins, including calbindin, allow it to bind to these molecules and participate in their signaling pathways.

This interactivity with other molecules has led to the hypothesis that DPP7 may be involved in a variety of physiological processes, including stress responses, inflammation, and tissue repair. In addition, its expression has been seen in a variety of tissues and organs, which suggests that it may be involved in a wide range of cellular processes throughout the body.

DPP7 has also been shown to be involved in the regulation of pain perception and the modulation of pain modalities. Studies have shown that DPP7 is involved in the production of pain-related molecules, including nitric oxide, which is involved in the regulation of blood flow and the delivery of pain signals to the brain.

In addition to its potential role in pain regulation, DPP7 has also been shown to be involved in the regulation of inflammation and cellular stress. Its expression has been seen in a variety of inflammatory and stress-related tissues, including the gut, skin, and blood.

This involvement in inflammation and stress has led to the hypothesis that DPP7 may be a useful biomarker or drug target for a variety of inflammatory and neurodegenerative disorders. For example, DPP7 has been shown to be involved in the regulation of inflammation and pain in rheumatoid arthritis, a common form of inflammatory arthritis.

In addition, DPP7 has also been shown to be involved in the regulation of pancreatic function, which has led to the hypothesis that it may be a useful biomarker or drug target for pancreatic cancer, a particularly aggressive form of cancer.

The potential utility of DPP7 as a drug target or biomarker is due to its unique structure and function, as well as its ability to interact with a variety of molecules. Its potential as a drug target is due to its involvement in a variety of cellular processes, including signaling pathways, stress responses, and inflammation. Its potential as a biomarker is due to its ability to be regulated by various factors, including pain, inflammation, and stress, which can be used as a indicator of disease status.

In conclusion, DPP7 is a protein that has significant potential as a drug target or biomarker. Its unique structure and function, as well as its ability to interact with a variety of molecules, make it an attractive target for research into a wide range of diseases. Further research is needed to fully understand its role in cellular processes and its potential as a drug or biomarker.

Protein Name: Dipeptidyl Peptidase 7

Functions: Plays an important role in the degradation of some oligopeptides

The "DPP7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DPP7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets